How often does Loncar China Biopharma ETF pay dividends? What is the dividend yield for Loncar China Biopharma ETF?

Loncar China Biopharma ETF announced an annual dividend on Friday, October 13th. Shareholders of record on Tuesday, October 17th will be paid a dividend of $0.0674 per share on Wednesday, October 18th. The ex-dividend date is Monday, October 16th. Read our dividend analysis for CHNA .

What does CHNA invest in?

Loncar China Biopharma ETF is a equity fund issued by Exchange Traded Concepts. CHNA focuses on health care investments and follows the Loncar China BioPharma Index. The fund's investments total to approximately $3.74 million assets under management.

What stocks does Loncar China Biopharma ETF hold?

CHNA invests in 89 holdings. Some of the stocks in their portfolio include Legend Biotech (LEGN) , BeiGene (BGNE) , HUTCHMED (HCM) , Zai Lab (ZLAB) and LianBio (LIAN) .

What is the management fee for Loncar China Biopharma ETF?

Loncar China Biopharma ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for CHNA is 0.79%.

What other stocks do shareholders of Loncar China Biopharma ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China Biopharma ETF investors own include Baidu (BIDU) , Salesforce (CRM) , Capcom (CCOEY) , Alibaba Group (BABA) , Activision Blizzard (ATVI) , ArcBest (ARCB) , Advanced Micro Devices (AMD) and Analog Devices (ADI) .

NASDAQ:CHNA

Loncar China Biopharma ETF (CHNA) Price, Holdings, & News

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free CHNA Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $13.53
▼
$13.53
50-Day Range: $13.53
▼
$14.77
52-Week Range: $13.35
▼
$22.89

Volume: 100 shs
Average Volume: 538 shs
Market Capitalization: $3.79 million

Assets Under Management: $3.74 million
Dividend Yield: 0.44%
Net Expense Ratio: 0.79%

Stock Analysis Dividend Headlines Holdings Ratings Social Media

Get Loncar China Biopharma ETF alerts:

About Loncar China Biopharma ETF (NASDAQ:CHNA)

The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

CHNA ETF News Headlines

February 6, 2024 | investing.com

MiraeAsset TIGER China Biotech Solactive ETF (371470)

January 20, 2024 | investing.com

China Southern CSI Cmunctn Srvcs ETF (159511)

April 18, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

December 30, 2023 | nasdaq.com

This ETF Has Depth Needed for China Rebound

December 21, 2023 | money.usnews.com

China Bans Export of Rare Earths Processing Technologies

December 19, 2023 | msn.com

China Sinochem Buys Rare Venezuelan Oil Cargo After U.S. Suspends Sanctions - Sources

December 16, 2023 | investing.com

China Universal Nasdaq 100 ETF (QDII) (159660)

December 13, 2023 | investing.com

Amundi MSCI China A II ETF (C024)

April 18, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

December 12, 2023 | investing.com

2823 ETF Stock Price History

See More Headlines

Receive CHNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Exchange Traded Concepts
Fund Name: Loncar China Biopharma ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:CHNA
Inception Date: 8/14/2018
Fund Manager: Denise M. Krisko, Habib Moudachirou
Web: N/A
Phone: 14089961010

Fund Focus

Asset Class: Equity
Benchmark: Loncar China BioPharma Index
Category: Sector
Focus: Health Care
Development Level: Emerging Markets
Region: Asia-Pacific
Number of Holdings: 89

Fund Statistics

Assets Under Management: $3.74 million
Average Daily Volume: $1,200.80
Discount/Premium: -0.06%

Administrator, Advisor and Custodian

Administrator: U.S. Bancorp Fund Services, LLC
Advisor: Exchange Traded Concepts, LLC
Custodian: U.S. Bank, N.A.
Distributor: Quasar Distributors, LLC
Transfer Agent: U.S. Bank, N.A.
Trustee: N/A
Lead Market Maker: GTS

Miscellaneous

Outstanding Shares: 280,000
Beta: 0.67
Creation Unit: 50,000
Creation Fee: $750.00

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Loncar China Biopharma ETF Expenses

Type	CHNA	Health Care ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.79%	0.56%	0.54%	0.48%	0.51%
Other Expenses	0.00%	0.40%	0.54%	0.34%	0.58%
Total Expense	0.79%	0.72%	0.70%	0.58%	0.70%
Fee Waiver	0.00%	-0.53%	-0.55%	-0.22%	-0.57%
Net Expense	0.79%	0.60%	0.60%	0.54%	0.58%

Loncar China Biopharma ETF (CHNA) Holdings

Top 10 CHNA Holdings

AIM Vaccine Co Ltd Class H
Holding Weight: 4.27%
Legend Biotech(NASDAQ:LEGN)
Holding Weight: 3.11%
Sinopharm Group Co Ltd
Holding Weight: 2.54%
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H
Holding Weight: 2.36%
Wuxi AppTec Co Ltd
Holding Weight: 2.24%
BeiGene(NASDAQ:BGNE)
Holding Weight: 2.17%
Hansoh Pharmaceutical Group Co Ltd
Holding Weight: 2.12%
Sino Biopharmaceutical Ltd
Holding Weight: 2.12%
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Class H
Holding Weight: 2.05%
Shanghai Pharmaceuticals Holding Co Ltd Class H
Holding Weight: 2.04%

Full Holdings Details

Similar ETFs

CHNA ETF - Frequently Asked Questions

How often does Loncar China Biopharma ETF pay dividends? What is the dividend yield for Loncar China Biopharma ETF?: Loncar China Biopharma ETF announced an annual dividend on Friday, October 13th. Shareholders of record on Tuesday, October 17th will be paid a dividend of $0.0674 per share on Wednesday, October 18th. The ex-dividend date is Monday, October 16th.
Read our dividend analysis for CHNA.
What does CHNA invest in?: Loncar China Biopharma ETF is a equity fund issued by Exchange Traded Concepts. CHNA focuses on health care investments and follows the Loncar China BioPharma Index. The fund's investments total to approximately $3.74 million assets under management.
What stocks does Loncar China Biopharma ETF hold?: CHNA invests in 89 holdings. Some of the stocks in their portfolio include Legend Biotech (LEGN), BeiGene (BGNE), HUTCHMED (HCM), Zai Lab (ZLAB) and LianBio (LIAN).

What is the management fee for Loncar China Biopharma ETF?: Loncar China Biopharma ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for CHNA is 0.79%.
What other stocks do shareholders of Loncar China Biopharma ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China Biopharma ETF investors own include Baidu (BIDU), Salesforce (CRM), Capcom (CCOEY), Alibaba Group (BABA), Activision Blizzard (ATVI), ArcBest (ARCB), Advanced Micro Devices (AMD) and Analog Devices (ADI).

This page (NASDAQ:CHNA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Loncar China Biopharma ETF (CHNA) Price, Holdings, & News

About Loncar China Biopharma ETF (NASDAQ:CHNA)

CHNA ETF News Headlines

Fund Details

Fund Focus

Fund Statistics

Administrator, Advisor and Custodian

Miscellaneous

Loncar China Biopharma ETF Expenses

Loncar China Biopharma ETF (CHNA) Holdings

Top 10 CHNA Holdings

Similar ETFs

CHNA ETF - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info